All results
3 results for randomized double blind vehicle controlled multicenter phase iii study evaluate
-
Clinical Trials
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study of ALXN2050 (120 and 180 milligrams [mg]) in addition to background therapy…
-
Clinical Trials
This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…
-
News, Stories & Blog
The goal: achieving transformative improvement in long-term survival within the next decade for patients diagnosed with malignant brain tumors. To get there,…